Policy & Regulation
-
The Phenomenal Success of Semaglutide: A True Money Printing Machine!
2024-02-01In January 2023, Novo Nordisk released its financial report, revealing astounding global sales figures for their groundbreaking weight-loss drug, Semaglutide.
-
EU Revises Regulations on Alcoholic Beverage Categories and Additive Usage
2024-01-30The European Union (EU) has recently implemented new regulations pertaining to the categorization of alcoholic beverages and the usage of additives within certain alcoholic drinks.
-
Sino-Agri and Yangnong have reached a comprehensive strategic cooperation
2024-01-29On January 27, 2024, Sino-Agri and Yangnong held a strategic cooperation exchange meeting, jointly signed a strategic cooperation agreement, and formally became strategic partners.
-
China's Food Exports to South Korea Violate Regulations in January 2024 (Updated as of January 28th)
2024-01-29In January 2024, China's exports of food products to South Korea were found to be in violation of regulations.
-
Pay attention to REACH compliance! Five new hazardous chemicals added to ECHA SVHC candidate list
2024-01-26On January 23, 2024, the European Chemicals Agency (ECHA) added five new hazardous chemicals to the Substances of Very High Concern (SVHC) candidate list, and the list was officially updated to 240 items.
-
ALPHAMAB, 3D Medicines, and Glenmark Reach $700 Million Licensing Agreement for KN035
2024-01-25In a significant development, ALPHAMAB Biopharmaceuticals, in collaboration with 3D Medicines, has announced a groundbreaking licensing agreement worth over $700 million for their PD-L1 antibody drug, KN035.
-
Youdao Chemical's Chlorantraniliprole technical plant has reached production with a total capacity of 11,000 tons
2024-01-22Since the trial production in December 2023, after more than one month of commissioning and operation, the current indicators of Youdao Chemical's Chlorantraniliprole technical plant fully meet the design requirements and successfully reach production!
-
Unveiling the Chemical Transformation: White Phosphorus Reacts with Thionyl Chloride to Give Remarkable Products
2024-01-19This original article explores the intriguing reaction between white phosphorus and thionyl chloride, emphasizing its transformative nature and investigating its diverse applications in various industries.
-
Is the FDA Failing to Address the Serious Side Effects of a Widely Prescribed Asthma Medication?
2024-01-12In recent years, concerns have escalated regarding the potential side effects of a commonly prescribed asthma and allergy medication.
-
FDA Proposes Ban on Brominated Vegetable Oil Due to Health Risks
2024-01-11The Food and Drug Administration (FDA) has recently proposed a ban on the use of brominated vegetable oil (BVO), a food ingredient commonly found in certain beverages like Gatorade and Mountain Dew.
-
FDA Proposes Ban on Brominated Vegetable Oil Due to Health Risks
2024-01-11The Food and Drug Administration (FDA) has recently proposed a ban on the use of brominated vegetable oil (BVO), a food ingredient commonly found in certain beverages like Gatorade and Mountain Dew.
-
AiolosBio: The Middleman with an Eye for Opportunity in the Pharmaceutical Industry?
2024-01-10On January 9, pharmaceutical giant GlaxoSmithKline (GSK) announced its acquisition agreement with AiolosBio, a move aimed at strengthening its portfolio in the respiratory and inflammation drug market.
-
Can Lecanemab Revolutionize Alzheimer's Disease Treatment?
2024-01-10Alzheimer's disease (AD) poses a significant challenge worldwide, affecting millions of individuals and their families. However, a breakthrough may be on the horizon with the recent approval of Lecanemab-irmb, a novel drug developed by Eisai
-
Study Finds Semaglutide Lower Suicide Ideation Risk Compared to Other Diabetes and Obesity Medications
2024-01-10According to a new federally-funded study by the National Institutes of Health, the drugs semaglutide, commonly used to treat diabetes and obesity, have been found to reduce the risk of suicide ideation in patients compared to other medications used for t
-
Can Florida's Authorization to Import Prescription Drugs from Canada Lower Medication Prices?
2024-01-08In a groundbreaking move, the U.S. Food and Drug Administration (FDA) has granted Florida permission to directly import prescription drugs from Canada.
-
Is FDA Doing Enough to Ensure the Safety of Food Additives?
2024-01-08In a closely-watched development, California legislators recently passed a bill that could ban the sale of certain food additives in the state.
-
Announcement: ECHEMI Data Upgrade Notice
2024-01-04The ECHEMI data server will be upgraded. After the upgrade, the stability and data timeliness in 2024 can be significantly improved.
-
Are GLP-1 Receptor Agonists Linked to Hair Loss and Suicidal Thoughts?
2024-01-04The US Food and Drug Administration (FDA) is closely examining reports of potential side effects associated with certain medications like Ozempic, Mounjaro, and Wegovy.
-
Medytox Establishes U.S. Subsidiary to Expand BTX Market’s Global Reach
2024-01-03Meditox, a Korean botulinum toxin (BTX) manufacturer, said it has established a U.S. subsidiary, Luvantas, to enter the global market with its non-animal-derived liquid BTX preparation MT10109L.
-
Is Promethazine Hydrochloride Injection Putting Patients at Risk? FDA Alerts Healthcare Professionals
2023-12-28Is Promethazine Hydrochloride Injection Putting Patients at Risk? FDA Alerts Healthcare Professionals.
Hot News
-
ECHEMI平台投诉处罚规则 - ECHEMI platform complaint penalty rules
-
ECHEMI平台禁限售商品目录规则 - Announcement on the list of prohibited sales of Prohibited and Controlled Items on ECHEMI
-
ECHEMI禁售商品发布规则 Rules for the Release of Prohibited Products on ECHEMI.com
-
From August 1st, many shipping companies charge high port congestion fees!
-
Congestion in 116 ports around the world! The increase in freight rates will continue into the first half of next year!
-
Semaglutide initiates Phase III clinical trial of NASH in China
-
GlaxoSmithKline Pharmaceuticals Reports 11% Rise in Q1 Profit Driven by Strong Demand for Vaccines
-
GLP-1 competition: Semaglutide surpasses dulaglutide this year
-
Ecuador pesticides market: imports during 2022 reached 275.6 Mio USD and 53.5 Mio USD in Q1 2023
-
Styrene: Supply And Demand Change